Compassionate Use Expanded Access Treatment Program News Today : Breaking News, Live Updates & Top Stories | Vimarsana

MaaT Pharma to Provide Clinical Data for Lead Microbiome Ecosystem Therapeutic MaaT013 in Intestinal Acute GvHD at Virtual 47th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT)
Topline data from the Phase 2 HERACLES clinical trial with MaaT013 will be announced near-term
MaaT Pharma announced today that data from its early access program for lead microbiome ecosystem therapeutic, MaaT013, will be reported in an oral presentation at the virtual 47
th Annual Meeting of the European Society for Blood and Marrow Transplantation (EBMT) taking place from March 14 March 17, 2021. The data was previously presented at the American Society of Hematology in December 2020. MaaT013 is an enema formulation of a full ecosystem microbiota biotherapeutic characterized by a consistent high diversity and richness of microbial species derived from pooled healthy donors The results include data from 29 patients with gastrointestinal, acute Graft-versu ....

United States , Microbiota Biotherapeutic , Kostenloser Wertpapierhandel , Florent Malard , Laura Mittmann , American Society Of Hematology , Sorbonne University , European Medicines Agency , Drug Administration , Trophic Communications , Meeting Of The European Society For Blood , Compassionate Use Expanded Access Treatment Program , Graft Versus Host Disease , Annual Meeting , European Society , Marrow Transplantation , American Society , Associate Professor , Saint Antoine Hospital , On Demand Library , Successful And Safe Treatment Of Intestinal , Expanded Access Treatment Program , Maat Pharma , Orphan Drug Designation , Microbiome Ecosystem Therapies , ஒன்றுபட்டது மாநிலங்களில் ,